Efficacy of recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing lung disease of unknown etiology. Recombinant human soluble thrombomodulin (rhTM) is used for the management of acute exacerbation (AE) of IPF. The present review aimed to summarize the evidence and perform a meta-analysis of the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Baojun, Li, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282169/
https://www.ncbi.nlm.nih.gov/pubmed/32537001
http://dx.doi.org/10.3892/etm.2020.8709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282169/
https://www.ncbi.nlm.nih.gov/pubmed/32537001
http://dx.doi.org/10.3892/etm.2020.8709

Ejemplares similares